Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose vs standard-dose glucocorticoids for acute GVHD
NCT00929695Phase 3Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jun 2009
- Primary completion
- Jul 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of prednisone, methylprednisolone in Acute Graft-Versus-Host Disease (aGVHD), sponsored by Fred Hutchinson Cancer Center. Started Jun 2009; status: completed.
02
Drugs
prednisonemethylprednisolone
03
Conditions
Acute Graft-Versus-Host Disease (aGVHD)
Beyond the preview
Go deeper on NCT00929695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00929695.